Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 89

1.

Cancer-related gene expression is associated with disease severity and modifiable lifestyle factors in non-alcoholic fatty liver disease.

Arendt BM, Teterina A, Pettinelli P, Comelli EM, Ma DWL, Fung SK, McGilvray ID, Fischer SE, Allard JP.

Nutrition. 2019 Jun;62:100-107. doi: 10.1016/j.nut.2018.12.001. Epub 2018 Dec 13.

PMID:
30870804
2.

Integration of Genomic and Transcriptional Features in Pancreatic Cancer Reveals Increased Cell Cycle Progression in Metastases.

Connor AA, Denroche RE, Jang GH, Lemire M, Zhang A, Chan-Seng-Yue M, Wilson G, Grant RC, Merico D, Lungu I, Bartlett JMS, Chadwick D, Liang SB, Eagles J, Mbabaali F, Miller JK, Krzyzanowski P, Armstrong H, Luo X, Jorgensen LGT, Romero JM, Bavi P, Fischer SE, Serra S, Hafezi-Bakhtiari S, Caglar D, Roehrl MHA, Cleary S, Hollingsworth MA, Petersen GM, Thayer S, Law CHL, Nanji S, Golan T, Smith AL, Borgida A, Dodd A, Hedley D, Wouters BG, O'Kane GM, Wilson JM, Zogopoulos G, Notta F, Knox JJ, Gallinger S.

Cancer Cell. 2019 Feb 11;35(2):267-282.e7. doi: 10.1016/j.ccell.2018.12.010. Epub 2019 Jan 24.

PMID:
30686769
3.

Gross and microscopic changes of liver neoplasms and background hepatic structures following neoadjuvant therapy.

Hodgson A, Almansouri Z, Adeyi O, Fischer SE.

J Clin Pathol. 2019 Feb;72(2):112-119. doi: 10.1136/jclinpath-2018-205596. Review.

PMID:
30670563
4.

Altered hepatic genes related to retinol metabolism and plasma retinol in patients with non-alcoholic fatty liver disease.

Pettinelli P, Arendt BM, Teterina A, McGilvray I, Comelli EM, Fung SK, Fischer SE, Allard JP.

PLoS One. 2018 Oct 31;13(10):e0205747. doi: 10.1371/journal.pone.0205747. eCollection 2018.

5.

In nonalcoholic fatty liver disease, Roux-en-Y gastric bypass improves liver histology while persistent disease is associated with lower improvements in waist circumference and glycemic control.

Schwenger KJP, Fischer SE, Jackson T, Okrainec A, Allard JP.

Surg Obes Relat Dis. 2018 Sep;14(9):1233-1239. doi: 10.1016/j.soard.2018.06.007. Epub 2018 Jul 12.

PMID:
30049593
6.

Organoid Profiling Identifies Common Responders to Chemotherapy in Pancreatic Cancer.

Tiriac H, Belleau P, Engle DD, Plenker D, Deschênes A, Somerville TDD, Froeling FEM, Burkhart RA, Denroche RE, Jang GH, Miyabayashi K, Young CM, Patel H, Ma M, LaComb JF, Palmaira RLD, Javed AA, Huynh JC, Johnson M, Arora K, Robine N, Shah M, Sanghvi R, Goetz AB, Lowder CY, Martello L, Driehuis E, LeComte N, Askan G, Iacobuzio-Donahue CA, Clevers H, Wood LD, Hruban RH, Thompson E, Aguirre AJ, Wolpin BM, Sasson A, Kim J, Wu M, Bucobo JC, Allen P, Sejpal DV, Nealon W, Sullivan JD, Winter JM, Gimotty PA, Grem JL, DiMaio DJ, Buscaglia JM, Grandgenett PM, Brody JR, Hollingsworth MA, O'Kane GM, Notta F, Kim E, Crawford JM, Devoe C, Ocean A, Wolfgang CL, Yu KH, Li E, Vakoc CR, Hubert B, Fischer SE, Wilson JM, Moffitt R, Knox J, Krasnitz A, Gallinger S, Tuveson DA.

Cancer Discov. 2018 Sep;8(9):1112-1129. doi: 10.1158/2159-8290.CD-18-0349. Epub 2018 May 31.

PMID:
29853643
7.

The surveillance of pre-mRNA splicing is an early step in C. elegans RNAi of endogenous genes.

Newman MA, Ji F, Fischer SEJ, Anselmo A, Sadreyev RI, Ruvkun G.

Genes Dev. 2018 May 1;32(9-10):670-681. doi: 10.1101/gad.311514.118. Epub 2018 May 8.

8.

Nonalcoholic fatty liver disease is associated with dysbiosis independent of body mass index and insulin resistance.

Da Silva HE, Teterina A, Comelli EM, Taibi A, Arendt BM, Fischer SE, Lou W, Allard JP.

Sci Rep. 2018 Jan 23;8(1):1466. doi: 10.1038/s41598-018-19753-9.

9.

Genomics-Driven Precision Medicine for Advanced Pancreatic Cancer: Early Results from the COMPASS Trial.

Aung KL, Fischer SE, Denroche RE, Jang GH, Dodd A, Creighton S, Southwood B, Liang SB, Chadwick D, Zhang A, O'Kane GM, Albaba H, Moura S, Grant RC, Miller JK, Mbabaali F, Pasternack D, Lungu IM, Bartlett JMS, Ghai S, Lemire M, Holter S, Connor AA, Moffitt RA, Yeh JJ, Timms L, Krzyzanowski PM, Dhani N, Hedley D, Notta F, Wilson JM, Moore MJ, Gallinger S, Knox JJ.

Clin Cancer Res. 2018 Mar 15;24(6):1344-1354. doi: 10.1158/1078-0432.CCR-17-2994. Epub 2017 Dec 29.

10.

Health-Seeking Behavior and Barriers to Care in Patients With Rectal Bleeding in Nigeria.

Alatise OI, Fischer SE, Ayandipo OO, Omisore AG, Olatoke SA, Kingham TP.

J Glob Oncol. 2017 Dec;3(6):749-756. doi: 10.1200/JGO.2016.006601. Epub 2017 Feb 1.

11.

Non-alcoholic Fatty Liver Disease in Morbidly Obese Individuals Undergoing Bariatric Surgery: Prevalence and Effect of the Pre-Bariatric Very Low Calorie Diet.

Schwenger KJP, Fischer SE, Jackson TD, Okrainec A, Allard JP.

Obes Surg. 2018 Apr;28(4):1109-1116. doi: 10.1007/s11695-017-2980-3.

PMID:
29098545
12.

Prospective comparison of gadoxetic acid-enhanced liver MRI and contrast-enhanced CT with histopathological correlation for preoperative detection of colorectal liver metastases following chemotherapy and potential impact on surgical plan.

Jhaveri KS, Fischer SE, Hosseini-Nik H, Sreeharsha B, Menezes RJ, Gallinger S, Moulton CE.

HPB (Oxford). 2017 Nov;19(11):992-1000. doi: 10.1016/j.hpb.2017.06.014. Epub 2017 Jul 29.

13.

Adenoma Prevalence in Blacks and Whites Having Equal Adherence To Screening Colonoscopy: The National Colonoscopy Study.

Mendelsohn RB, Winawer SJ, Jammula A, Mills G, Jordan P, O'Brien MJ, Close GM, Dorfman M, Church TR, Mandelson MT, Allen J, Feld A, Kauff ND, Morgan GA, Kumar JMR, Serrano V, Bayuga-Miller S, Fischer SE, Kuk D, Zauber AG.

Clin Gastroenterol Hepatol. 2017 Sep;15(9):1469-1470. doi: 10.1016/j.cgh.2017.04.014. Epub 2017 Apr 15. No abstract available.

14.

Establishing a Cancer Research Consortium in Low- and Middle-Income Countries: Challenges Faced and Lessons Learned.

Fischer SE, Alatise OI, Komolafe AO, Katung AI, Egberongbe AA, Olatoke SA, Agodirin OS, Kolawole OA, Olaofe OO, Ayandipo OO, Rotimi O, Brennan MF, Kingham TP.

Ann Surg Oncol. 2017 Mar;24(3):627-631. doi: 10.1245/s10434-016-5624-2. Epub 2016 Oct 14.

15.

Estimation of Benefits, Burden, and Harms of Colorectal Cancer Screening Strategies: Modeling Study for the US Preventive Services Task Force.

Knudsen AB, Zauber AG, Rutter CM, Naber SK, Doria-Rose VP, Pabiniak C, Johanson C, Fischer SE, Lansdorp-Vogelaar I, Kuntz KM.

JAMA. 2016 Jun 21;315(23):2595-609. doi: 10.1001/jama.2016.6828.

16.

Power and Agenda-Setting in Tanzanian Health Policy: An Analysis of Stakeholder Perspectives.

Fischer SE, Strandberg-Larsen M.

Int J Health Policy Manag. 2016 Feb 9;5(6):355-63. doi: 10.15171/ijhpm.2016.09.

17.

Bile Acids and Dysbiosis in Non-Alcoholic Fatty Liver Disease.

Mouzaki M, Wang AY, Bandsma R, Comelli EM, Arendt BM, Zhang L, Fung S, Fischer SE, McGilvray IG, Allard JP.

PLoS One. 2016 May 20;11(5):e0151829. doi: 10.1371/journal.pone.0151829. eCollection 2016.

18.

Evidence-Based, Reality-Driven Colorectal Cancer Screening Guidelines: The Critical Relationship of Adherence to Effectiveness.

Winawer SJ, Fischer SE, Levin B.

JAMA. 2016 May 17;315(19):2065-6. doi: 10.1001/jama.2016.3377. No abstract available.

PMID:
27187294
19.

Diffusion-weighted and hepatobiliary phase gadoxetic acid-enhanced quantitative MR imaging for identification of complete pathologic response in colorectal liver metastases after preoperative chemotherapy.

Hosseini-Nik H, Fischer SE, Moulton CA, Karbhase G, Menezes RJ, Gallinger S, Jhaveri KS.

Abdom Radiol (NY). 2016 Feb;41(2):231-8. doi: 10.1007/s00261-015-0572-z.

PMID:
26867904
20.

Sinorhizobium meliloti low molecular mass phosphotyrosine phosphatase SMc02309 modifies activity of the UDP-glucose pyrophosphorylase ExoN involved in succinoglycan biosynthesis.

Medeot DB, Romina Rivero M, Cendoya E, Contreras-Moreira B, Rossi FA, Fischer SE, Becker A, Jofré E.

Microbiology. 2016 Mar;162(3):552-63. doi: 10.1099/mic.0.000239. Epub 2016 Jan 25.

PMID:
26813656
21.

Protease inhibitors partially overcome the interferon nonresponse phenotype in patients with chronic hepatitis C.

Duarte-Rojo A, Fischer SE, Adeyi O, Zita D, Deneke MG, Selzner N, Chen L, Malespin M, Cotler SJ, McGilvray ID, Feld JJ.

J Viral Hepat. 2016 May;23(5):340-7. doi: 10.1111/jvh.12494. Epub 2015 Dec 29.

PMID:
26710754
22.

RNA Interference and MicroRNA-Mediated Silencing.

Fischer SE.

Curr Protoc Mol Biol. 2015 Oct 1;112:26.1.1-5. doi: 10.1002/0471142727.mb2601s112. Review.

PMID:
26423588
23.

Draft Genome Sequences of Pseudomonas fluorescens Strains SF39a and SF4c, Potential Plant Growth Promotion and Biocontrol Agents.

Ly LK, Underwood GE, McCully LM, Bitzer AS, Godino A, Bucci V, Brigham CJ, Príncipe A, Fischer SE, Silby MW.

Genome Announc. 2015 Mar 26;3(2). pii: e00219-15. doi: 10.1128/genomeA.00219-15.

24.

Altered hepatic gene expression in nonalcoholic fatty liver disease is associated with lower hepatic n-3 and n-6 polyunsaturated fatty acids.

Arendt BM, Comelli EM, Ma DW, Lou W, Teterina A, Kim T, Fung SK, Wong DK, McGilvray I, Fischer SE, Allard JP.

Hepatology. 2015 May;61(5):1565-78. doi: 10.1002/hep.27695. Epub 2015 Feb 27.

PMID:
25581263
25.

Liver Failure After Abdominal Irradiation: Identifying the Right Suspects.

Dal Pra A, Berlin A, Kumareswaran R, Schattner AJ, Craig T, Wong D, Hodgson D, Fischer SE, Bristow RG, Dawson LA.

J Clin Oncol. 2016 Mar 20;34(9):e80-3. doi: 10.1200/JCO.2013.50.9547. Epub 2014 Jul 28. No abstract available.

PMID:
25071139
26.

Endogenous RNAi pathways in C. elegans.

Billi AC, Fischer SE, Kim JK.

WormBook. 2014 May 7:1-49. doi: 10.1895/wormbook.1.170.1. Review.

27.

Multiple small RNA pathways regulate the silencing of repeated and foreign genes in C. elegans.

Fischer SE, Pan Q, Breen PC, Qi Y, Shi Z, Zhang C, Ruvkun G.

Genes Dev. 2013 Dec 15;27(24):2678-95. doi: 10.1101/gad.233254.113.

28.

SHILO, a novel dual imaging approach for simultaneous HI-/LOw temporal (Low-/Hi-spatial) resolution imaging for vascular dynamic contrast enhanced cardiovascular magnetic resonance: numerical simulations and feasibility in the carotid arteries.

Calcagno C, Robson PM, Ramachandran S, Mani V, Kotys-Traughber M, Cham M, Fischer SE, Fayad ZA.

J Cardiovasc Magn Reson. 2013 May 24;15:42. doi: 10.1186/1532-429X-15-42.

29.

Intestinal microbiota in patients with nonalcoholic fatty liver disease.

Mouzaki M, Comelli EM, Arendt BM, Bonengel J, Fung SK, Fischer SE, McGilvray ID, Allard JP.

Hepatology. 2013 Jul;58(1):120-7. doi: 10.1002/hep.26319. Epub 2013 May 14.

PMID:
23401313
30.

The Caenorhabditis elegans RDE-10/RDE-11 complex regulates RNAi by promoting secondary siRNA amplification.

Zhang C, Montgomery TA, Fischer SE, Garcia SM, Riedel CG, Fahlgren N, Sullivan CM, Carrington JC, Ruvkun G.

Curr Biol. 2012 May 22;22(10):881-90. doi: 10.1016/j.cub.2012.04.011. Epub 2012 Apr 26.

31.

PIWI associated siRNAs and piRNAs specifically require the Caenorhabditis elegans HEN1 ortholog henn-1.

Montgomery TA, Rim YS, Zhang C, Dowen RH, Phillips CM, Fischer SE, Ruvkun G.

PLoS Genet. 2012;8(4):e1002616. doi: 10.1371/journal.pgen.1002616. Epub 2012 Apr 19.

32.

Three-dimensional characterization of resorption cavity size and location in human vertebral trabecular bone.

Goff MG, Slyfield CR, Kummari SR, Tkachenko EV, Fischer SE, Yi YH, Jekir MG, Keaveny TM, Hernandez CJ.

Bone. 2012 Jul;51(1):28-37. doi: 10.1016/j.bone.2012.03.028. Epub 2012 Apr 3.

33.

Mechanical failure begins preferentially near resorption cavities in human vertebral cancellous bone under compression.

Slyfield CR, Tkachenko EV, Fischer SE, Ehlert KM, Yi IH, Jekir MG, O'Brien RG, Keaveny TM, Hernandez CJ.

Bone. 2012 Jun;50(6):1281-7. doi: 10.1016/j.bone.2012.02.636. Epub 2012 Mar 9.

34.

Patients with autoimmune hepatitis who have antimitochondrial antibodies need long-term follow-up to detect late development of primary biliary cirrhosis.

Dinani AM, Fischer SE, Mosko J, Guindi M, Hirschfield GM.

Clin Gastroenterol Hepatol. 2012 Jun;10(6):682-4. doi: 10.1016/j.cgh.2012.02.010. Epub 2012 Feb 22.

PMID:
22366178
35.

Orthogonal CSPAMM (OCSPAMM) MR tagging for imaging ventricular wall motion.

Wang H, Kadbi M, Kotys M, Ersoy M, Chatzimavroudis GP, Setser RM, Alshaher M, Fischer SE, Amini AA.

Conf Proc IEEE Eng Med Biol Soc. 2011;2011:535-8. doi: 10.1109/IEMBS.2011.6090098.

PMID:
22254366
36.

The ERI-6/7 helicase acts at the first stage of an siRNA amplification pathway that targets recent gene duplications.

Fischer SE, Montgomery TA, Zhang C, Fahlgren N, Breen PC, Hwang A, Sullivan CM, Carrington JC, Ruvkun G.

PLoS Genet. 2011 Nov;7(11):e1002369. doi: 10.1371/journal.pgen.1002369. Epub 2011 Nov 10.

37.

mut-16 and other mutator class genes modulate 22G and 26G siRNA pathways in Caenorhabditis elegans.

Zhang C, Montgomery TA, Gabel HW, Fischer SE, Phillips CM, Fahlgren N, Sullivan CM, Carrington JC, Ruvkun G.

Proc Natl Acad Sci U S A. 2011 Jan 25;108(4):1201-8. doi: 10.1073/pnas.1018695108. Epub 2011 Jan 18.

38.

Baseline ductopenia and treatment response predict long-term histological progression in primary biliary cirrhosis.

Kumagi T, Guindi M, Fischer SE, Arenovich T, Abdalian R, Coltescu C, Heathcote EJ, Hirschfield GM.

Am J Gastroenterol. 2010 Oct;105(10):2186-94. doi: 10.1038/ajg.2010.216. Epub 2010 May 25.

PMID:
20502446
39.

Small RNA-mediated gene silencing pathways in C. elegans.

Fischer SE.

Int J Biochem Cell Biol. 2010 Aug;42(8):1306-15. doi: 10.1016/j.biocel.2010.03.006. Epub 2010 Mar 19. Review.

PMID:
20227516
40.

Non-viral-related pathologic findings in liver needle biopsy specimens from patients with chronic viral hepatitis.

Nair V, Fischer SE, Adeyi OA.

Am J Clin Pathol. 2010 Jan;133(1):127-32. doi: 10.1309/AJCP8D7ILBHPSDOK.

PMID:
20023268
41.

Survival of native Pseudomonas in soil and wheat rhizosphere and antagonist activity against plant pathogenic fungi.

Fischer SE, Jofré EC, Cordero PV, Gutiérrez Mañero FJ, Mori GB.

Antonie Van Leeuwenhoek. 2010 Mar;97(3):241-51. doi: 10.1007/s10482-009-9405-9. Epub 2009 Dec 19.

PMID:
20020326
42.

RNA editing genes associated with extreme old age in humans and with lifespan in C. elegans.

Sebastiani P, Montano M, Puca A, Solovieff N, Kojima T, Wang MC, Melista E, Meltzer M, Fischer SE, Andersen S, Hartley SH, Sedgewick A, Arai Y, Bergman A, Barzilai N, Terry DF, Riva A, Anselmi CV, Malovini A, Kitamoto A, Sawabe M, Arai T, Gondo Y, Steinberg MH, Hirose N, Atzmon G, Ruvkun G, Baldwin CT, Perls TT.

PLoS One. 2009 Dec 14;4(12):e8210. doi: 10.1371/journal.pone.0008210. Erratum in: PLoS One. 2009;4(12) doi: 10.1371/annotation/387f8074-5f80-4bdd-bb0b-b36d49a16ac0.

43.

Liver allograft pathology: approach to interpretation of needle biopsies with clinicopathological correlation.

Adeyi O, Fischer SE, Guindi M.

J Clin Pathol. 2010 Jan;63(1):47-74. doi: 10.1136/jcp.2009.068254. Epub 2009 Oct 21. Review.

PMID:
19847014
44.

Biofunctional coatings via targeted covalent cross-linking of associating triblock proteins.

Fischer SE, Mi L, Mao HQ, Harden JL.

Biomacromolecules. 2009 Sep 14;10(9):2408-17. doi: 10.1021/bm900202z.

PMID:
19655714
45.

Trans-splicing in C. elegans generates the negative RNAi regulator ERI-6/7.

Fischer SE, Butler MD, Pan Q, Ruvkun G.

Nature. 2008 Sep 25;455(7212):491-6. doi: 10.1038/nature07274. Epub 2008 Sep 10.

46.

Mice lacking the transcription factor Ikaros display behavioral alterations of an anti-depressive phenotype.

Kiehl TR, Fischer SE, Ezzat S, Asa SL.

Exp Neurol. 2008 May;211(1):107-14. doi: 10.1016/j.expneurol.2008.01.014. Epub 2008 Feb 5.

PMID:
18313668
47.

Biocontrol and PGPR features in native strains isolated from saline soils of Argentina.

Príncipe A, Alvarez F, Castro MG, Zacchi LF, Fischer SE, Mori GB, Jofré E.

Curr Microbiol. 2007 Oct;55(4):314-22. Epub 2007 Aug 13. Erratum in: Curr Microbiol. 2014 Sep;69(3):404. Zachi, Lucía [corrected to Zacchi, Lucı F].

PMID:
17700983
48.

Gastric mucin is expressed in a subset of endocervical tunnel clusters: type A tunnel clusters of gastric phenotype.

Kondo T, Hashi A, Murata SI, Fischer SE, Nara M, Nakazawa T, Yuminamochi T, Hoshi K, Katoh R.

Histopathology. 2007 Jun;50(7):843-50.

PMID:
17543073
49.

Controlling cell adhesion to surfaces via associating bioactive triblock proteins.

Fischer SE, Liu X, Mao HQ, Harden JL.

Biomaterials. 2007 Aug;28(22):3325-37. Epub 2007 Apr 5.

PMID:
17459470
50.

Quantifying effects of retinal illuminance on frequency doubling perimetry.

Swanson WH, Dul MW, Fischer SE.

Invest Ophthalmol Vis Sci. 2005 Jan;46(1):235-40.

PMID:
15623778

Supplemental Content

Loading ...
Support Center